From Guidelines to Consolidation and Beyond: Evidence-Based Strategies to Optimize Outcomes in Unresectable Stage III NSCLC

NOV 19, 202614 MIN

Description

Please visit answersincme.com/UMN860 to participate, download slides and supporting materials, complete the post test, and get a certificate. Presented by Ticiana Leal, MD. In this activity, an expert in thoracic oncology discusses evidence-based strategies to optimize outcomes in unresectable stage III non–small-cell lung cancer (NSCLC). Upon completion of this activity, participants should be better able to: Discuss the guideline recommendations for consolidation therapy in patients with unresectable stage III NSCLC; Review the evidence for consolidation therapy in patients with unresectable stage III NSCLC, including pivotal and emerging data informing locally advanced immunotherapy strategies; and Recommend evidence-based, practical strategies to optimize management of appropriate patients with unresectable stage III NSCLC using consolidation therapy.